Dr Caroline Gargett from Monash Institute of Medical Research (MIMR) has discovered adult stem cells in the uterus that can be grown into bone, muscle, fat and cartilage and her research has been hailed as a major medical and scientific development by international reproduction experts.
Chemists at the University of California, Riverside have synthesised a new class of carbenes - molecules that have unusual carbon atoms - that is expected to have wide applications in the pharmaceutical industry, ultimately resulting in a reduction in the price of drugs.
If living cell is replaced by a test-tube with DNA and a set of substances, it is possible to get proteins in a more simple and inexpensive way. That was done by Russian biochemists synthesising insulin without help of transgene Escherichia coli.
An analysis method permitting the simultaneous quantification of numerous parameters in the immune system was recently presented at the Campus Vienna Biocenter. The technology, which has been developed by Bender MedSystems, is based on the principle of a widespread analysis device and thus allows for rapid implementation in daily laboratory life. It thus succeeds in satisfying the growing demand at clinical and pharmaceutical organisations for increasingly efficient analysis methods at favourable costs.
Testable genetic differences might be used to predict the effectiveness of a medication commonly prescribed to treat attention deficit hyperactivity disorder, a new study suggests.
Researchers at The University of Texas MD Anderson Cancer Centre say they have discovered a potential oncongene in ovarian cancer, which is the leading cause of gynaecological cancer death in US women.
A portable biosensing device based on micro- and nanotechnologies is expected to help doctors rapidly and accurately forewarn patients of their genetic risk of developing diseases such as cancer.
DiagnoSwiss and bioMerieux have signed an exclusive licence agreement for the development and use of DiagnoSwiss electrochemical microchips in human in vitro diagnostics.
A pain drug development company spun out of The University of Queensland has received a $3.25 million investment commitment to develop its innovative pain therapy.
Patients suffering from oral cancer have increased levels of certain bacteria in their saliva, according to research published in the Open Access journal, Journal of Translational Medicine. Six common species of bacteria were found at significantly higher levels in the saliva of patients with oral squamous cell carcinoma (OSCC) than in the saliva of healthy individuals. The researchers were able to use three of the six species as a diagnostic tool to predict more than 80% of oral cancer cases. These preliminary findings indicate that three species of bacteria may be incidentally or causally linked with OSCC, and if so detection of these species could be used as a simple, rapid and non-invasive saliva test to diagnose oral cancer.
Using a water droplet 1 trillion times smaller than a litre of soda as a sort of nanoscale test tube, a University of Washington scientist is conducting chemical analysis and experimentation at unprecedented tiny scales.
Physicists in Singapore have created the first paper battery that generates electricity from urine.
The Australian science industry has grown in the last few years. While the progress being made by Australian industries is impressive, there are still many ways in which to improve efficiency and marketability on a global market
Two researchers from Queensland are contributing to a $436 million global plan to improve the health of millions of people in some of the world's poorest countries.
A team of international scientists â€“ including Australians â€“ has made a breakthrough in solving the problem that had put the development of marine-derived pharmaceuticals on hold for years.